Neuropeptides in the human appendix. Distribution and motor effects.
At present our knowledge of enteric peptide-containing neurons in man is limited. In this study we have used human appendices removed at surgery to examine the peptidergic innervation by immunocytochemistry, immunochemistry, and pharmacological in vitro experiments. Immunocytochemistry revealed a variety of peptide-containing nerve fiber populations in the human appendix. VIP/PHI-, VIP/PHI/NPY-, SP/NKA-, galanin-, and enkephalin-containing nerve fibers were numerous; CGRP- and GRP-containing nerve fibers were moderate in number, while only scattered NPY-, enkephalin/BAM-, and somatostatin-containing nerve fibers could be found. No CCK-, dynorphin A-, or dynorphin B-immunoreactive nerve fibers could be detected. The coexistence of VIP/PHI, SP/NKA, and enkaphalin/BAM can be anticipated from the known sequence of their respective precursors. However, the coexistence of VIP/PHI and NPY was unexpected but corroborates previous observations in other species. Interestingly, SP and CGRP did not seem to coexist in nerve fibers of the human appendix. Immunochemistry (RIA and HPLC) confirmed the presence of VIP, NPY, SP, galanin, CGRP, GRP, enkephalin, and somatostatin. Motor activity studies suggest that acetylcholine plays a major role in the electrically evoked contractions, since atropine suppressed these contractions. Galanin (10(-8)-10(-6) M) and GRP (10(-9)-10(-7) M) caused concentration-dependent contractions that were unaffected by tetrodotoxin and thus probably reflect a direct action on smooth muscle receptors. GRP (10(-9) M) enhanced the electrically induced cholinergic contraction (to 193 +/- 24%), while met-enkephalin (10(-6) M) reduced it (to 54 +/- 6%). Both peptides failed to affect the contractile response to exogenous acetylcholine and probably act to modulate the release of acetylcholine. NPY, VIP, CGRP, SP, and somatostatin failed to induce contraction or to affect the electrically evoked contractions.
Ekblad
E
E
Department of Medical Cell Research, Lund, Sweden.
Arnbjörnsson
E
E
Ekman
R
R
Håkanson
R
R
Sundler
F
F
D001065:Appendix / Q000294:innervation* / Q000502:physiology; D015740:Calcitonin Gene-Related Peptide; D004744:Enkephalin, Methionine / Q000031:analogs & derivatives / Q000032:analysis; D004745:Enkephalins / Q000032:analysis; D019004:Galanin; D019886:Gastrin-Releasing Peptide; D006801:Humans; D007150:Immunohistochemistry; D066298:In Vitro Techniques; D009119:Muscle Contraction; D009130:Muscle, Smooth / Q000502:physiology; D015288:Neurokinin A / Q000032:analysis; D009474:Neurons / Q000032:analysis*; D009478:Neuropeptide Y / Q000032:analysis; D009479:Neuropeptides / Q000032:analysis*; D010451:Peptide PHI / Q000032:analysis; D010455:Peptides / Q000032:analysis; D011498:Protein Precursors / Q000032:analysis; D013004:Somatostatin / Q000032:analysis; D013373:Substance P / Q000032:analysis; D014660:Vasoactive Intestinal Peptide / Q000032:analysis
D004745:Enkephalins; D009478:Neuropeptide Y; D009479:Neuropeptides; D010451:Peptide PHI; D010455:Peptides; D011498:Protein Precursors; D013373:Substance P; D014660:Vasoactive Intestinal Peptide; D013004:Somatostatin; D004744:Enkephalin, Methionine; C028837:BAM 22P; D019886:Gastrin-Releasing Peptide; D015288:Neurokinin A; D019004:Galanin; D015740:Calcitonin Gene-Related Peptide